Latest Regulatory News

Argosy Minerals has reported significant progress on its flagship Rincon Lithium Project, including an upgraded mineral resource estimate and advancing engineering and feasibility studies toward a 12,000tpa lithium carbonate operation.

Pacific Edge announces a two-month delay in the Medicare Local Coverage Determination for its genetic oncology tests, extending the effective date to April 24, 2025. This extension follows the company’s active engagement with US regulatory bodies.

Energy Transition Minerals Ltd has issued a prospectus offering up to 68.75 million free-attaching quoted options to placement participants as part of a $9.35 million capital raising. The options, exercisable at $0.12 and expiring in 18 months, aim to support expansion in Greenland and project development despite ongoing litigation risks.

CZR Resources updates investors on the extended FIRB approval timeline for its Robe Mesa Iron Ore Project sale, highlighting amended transaction terms that allow termination before the new February deadline.

Sagalio Energy reported stable production of 510 tons of oil and sales revenue of nearly US$124,000 for the December 2024 quarter, navigating slight price volatility while expanding output modestly.

Perpetual Resources reports significant assay results confirming ultra-high grade spodumene at its Isabella Lithium Project and initiates metallurgical testing at the Raptor Rare Earth Project, backed by a strategic MOU with Minas Gerais government and a $1 million capital raise.

Key Petroleum Limited progresses Potential Commercial Area applications for ATPs 920 and 924 in Queensland’s Cooper Eromanga Basin, supported by a recent capital raise despite a constrained cash balance.

Auswide Bank has secured Treasurer approval for MyState Bank’s acquisition via a scheme of arrangement, setting the stage for a pivotal shareholder vote in early February.

MyState Limited has secured Federal Treasurer approval for its merger with Auswide Bank, advancing plans to create a larger regional banking group pending shareholder and court consent.

Astron Corporation has responded to ASX concerns over a delayed Appendix 3Y filing, attributing the lag to director travel and reaffirming its compliance protocols.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

K-TIG Limited is set to transform its business with a $7–10 million capital raise to acquire US-based Metal Powder Works, issuing performance-based vendor shares that an independent expert deems fair and reasonable.